EKF is in rude financial health
Buy EKF Diagnostics (EKF:AIM) ahead of possible earnings upgrades in the wake of strong full-year results (18 Mar).The medical equipment play is benefiting from a focus on high-margin products. Earnings before interest, tax,...
24 January 2013
